Using ant? Genos a33 and jam-it.

Polypeptide for use in treating an inflammatory disease associated with overexpression of STlgMA, wherein the polypeptide comprises the sequence of the extracellular domain (ECD) of a STlgMA polypeptide fused to a sequence immunoglobulin constant region, wherein the polypeptide Stigma has at least 80% identity in amino acid sequence to a polypeptide selected from the group consisting of SEQ ID NOs: 32, 33 and 34, with or without the native signal sequence, with or without the initiating methionine with or without all or part of the potential transmembrane domain, and with or without the intracellular domain.